NASDAQ:IVTY - Invuity Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$7.39
Today's Range$7.39 - $7.39
52-Week Range$2.35 - $9.55
Average Volume324,995 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. The company through its intelligent photonics technology platform develops single-use and reusable illuminated surgical devices, which provide surgeons with illumination and direct visualization of surgical cavities. It offers various illuminated surgical devices, including Eikon LT illuminated retractor system for breast/oncoplastic/gynecology/EP/plastic/endocrine surgeries; Eiberg illuminated retractor systems for orthopedic surgeries; PhotonBlade, a recision illuminator for breast/plastics/EP/orthopedics surgeries; PhotonSaber Y, a handheld illuminator for orthopedic/spine/cardiothoracic/breast/general/gynecology/plastic surgeries; and PhotonSaber F, a handheld illuminator for spine/orthopedic/neurosurgery surgeries. The company also provides Breiten illuminated retractor systems for spine/orthopedic surgeries; Photonguide XT system, a drop-in intracavity illuminator for spine surgeries; Eika illuminated retractor systems for endocrine/spine/orthopedic surgeries; and PhotonVue, a system used in conjunction with IC Indocyanine for identifying and verifying blood flow in tissue, as well as is used in breast/plastic/colorectal surgeries. It sells its devices through direct sales representatives and independent sales agents; and directly to hospitals and surgeons, as well as to third-party medical device manufacturers. The company was formerly known as Spotlight Surgical, Inc. and changed its name to Invuity, Inc. in 2007. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California.

Receive IVTY News and Ratings via Email

Sign-up to receive the latest news and ratings for IVTY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolNASDAQ:IVTY



Sales & Book Value

Annual SalesN/A



OptionableNot Optionable

Invuity (NASDAQ:IVTY) Frequently Asked Questions

What is Invuity's stock symbol?

Invuity trades on the NASDAQ under the ticker symbol "IVTY."

How were Invuity's earnings last quarter?

Invuity Inc (NASDAQ:IVTY) posted its quarterly earnings data on Thursday, August, 2nd. The medical instruments supplier reported ($0.37) EPS for the quarter, topping the Zacks' consensus estimate of ($0.47) by $0.10. The medical instruments supplier had revenue of $10.50 million for the quarter, compared to analyst estimates of $10.73 million. View Invuity's Earnings History.

What price target have analysts set for IVTY?

5 brokerages have issued twelve-month price objectives for Invuity's shares. Their forecasts range from $5.00 to $5.00. On average, they expect Invuity's stock price to reach $5.00 in the next year. View Analyst Price Targets for Invuity.

What is the consensus analysts' recommendation for Invuity?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Invuity in the last year. There are currently 5 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Invuity.

Has Invuity been receiving favorable news coverage?

News stories about IVTY stock have been trending somewhat positive on Tuesday, according to InfoTrie. The research firm identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Invuity earned a news impact score of 0.9 on InfoTrie's scale. They also gave news articles about the medical instruments supplier a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

Who are some of Invuity's key competitors?

Who are Invuity's key executives?

Invuity's management team includes the folowing people:
  • Mr. Scott D. Flora, Interim Pres, CEO & Director (Age 62)
  • Mr. Philip M. Sawyer, CEO, Pres & Director (Age 53)
  • Mr. James H. MacKaness, Chief Financial Officer (Age 54)
  • Mr. Douglas W. Heigel, Sr. VP of Operations (Age 57)
  • Ms. Marcia Fish, Chief HR Officer (Age 54)

When did Invuity IPO?

(IVTY) raised $48 million in an IPO on the week of June 15th 2015. The company issued 4,000,000 shares at a price of $12.00 per share. Piper Jaffray, Leerink Partners and Stifel served as the underwriters for the IPO and William Blair was co-manager.

How do I buy shares of Invuity?

Shares of IVTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Invuity's official website?

The official website for Invuity is

How can I contact Invuity?

Invuity's mailing address is 444 DE HARO STREET, San Francisco CA, 94107. The medical instruments supplier can be reached via phone at 415-655-2100 or via email at [email protected]

MarketBeat Community Rating for Invuity (NASDAQ IVTY)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  193 (Vote Outperform)
Underperform Votes:  180 (Vote Underperform)
Total Votes:  373
MarketBeat's community ratings are surveys of what our community members think about Invuity and other stocks. Vote "Outperform" if you believe IVTY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IVTY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2019 by Staff

Featured Article: How mutual funds make money

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel